Skip to main content

Table 3 Clinical outcome after pump implantation

From: Periprocedural safety and outcome after pump implantation for intravenous treprostinil administration in patients with pulmonary arterial hypertension

 

Baseline (n = 54)

6-months-follow-up (n = 53*)

Lung-transplanted - n (%)

4

Deceased – n (%)

1

Right ventricular end-diastolic diameter 4 chamber view (mm)

56.6 ± 8.0

53.2 ± 8.4

Tricuspid annular plane systolic excursion (mm)

17 ± 4.6

17 ± 3.7

WHO-FC – n (%)

  

 Class 1

0 (0 %)

0 (0 %)

 Class 2

4 (7 %)

13 (30 %)

 Class 3

42 (78 %)

30 (63 %)

 Class 4

8 (15 %)

5 (12 %)

6 min walking distance (m)

345 ± 154

383 ± 142

NT-proBNP (ng/l)

2986 ± 2630

3164 ± 3889

Risk Score – n (%)**

  

 Low

4 (8 %)

13 (28 %)

 Intermediate

42 (78 %)

30 (65 %)

 High

8 (15 %)

3 (7 %)

  1. Continuous variables are presented as mean and standard deviation and categorical variables are presented as n and percent, unless stated otherwise
  2. *1 patient had no routine visit at 6 months (+-1 month)
  3. **Assessed by the Swedish/COMPERA method